Biofrontera Inc. (NASDAQ:BFRI – Get Free Report) was the recipient of a large decrease in short interest in the month of November. As of November 15th, there was short interest totalling 316,600 shares, a decrease of 30.7% from the October 31st total of 457,100 shares. Based on an average trading volume of 2,780,000 shares, the days-to-cover ratio is currently 0.1 days. Approximately 7.8% of the company’s shares are sold short.
Biofrontera Trading Down 9.1 %
Shares of BFRI opened at $0.90 on Friday. The stock’s 50-day moving average price is $0.94 and its two-hundred day moving average price is $1.04. Biofrontera has a 12 month low of $0.61 and a 12 month high of $4.00. The company has a market capitalization of $6.98 million, a PE ratio of -0.40 and a beta of 0.50.
Wall Street Analyst Weigh In
Separately, Benchmark reiterated a “buy” rating and set a $7.00 price target on shares of Biofrontera in a report on Friday, November 15th.
About Biofrontera
Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.
Featured Articles
- Five stocks we like better than Biofrontera
- Stock Splits, Do They Really Impact Investors?
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- 3 Small Caps With Big Return Potential
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- What is the FTSE 100 index?
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for Biofrontera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biofrontera and related companies with MarketBeat.com's FREE daily email newsletter.
